Sarms SR9011 CAS 1379686-29-9

SR9011 VS SR9009

The difference between SR9009 and SR9011 is the pharmacological effects on cancer cells and potency.

Treatments of a variety of cancer cell types with SR9009 and SR9011 (REV-ERBα and REV-ERBβ) led to significant cancer cell apoptosis without negatively impacting the healthy cells around the tumors.

Although both have tumor blocking effects, sr-9011 is the more potent of the two.

SR9011 Half-life: Hyper Lean 2.0 would have a 24-hour effect
SR9011 dawkowanie: 20 Do 30 milligrams (mg) per day

WhatsApp/Telegram/Sygnał :+44 7707 211100